In contrast, TSH receptor inhibition in combination with PD1 Ab reversed immune evasion by activation of Teffs and attenuation of PDL1 expression in tumors and monocyte-derived DCs, the main producers of TSH in the tumor tissue microenvironment. Here, CD274 is linked to neoplasm.